Roche Finance Ltd 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,334,113 4.400% | -253,641 (-9.80%) | Filing |
| 2021-02-16 07:02 am Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,587,754 5.100% | 2,587,754 (New Position) | Filing |